Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04126200 |
|---|---|
| Brief Title: | Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM5) |
| First Submitted : | October 11, 2019 |
| First Submitted that Met QC Criteria : | October 11, 2019 |
| First Posted : | October 15, 2019 |
| Last Update Submitted that Met QC Criteria : | February 23, 2024 |
| Last Update Posted : | February 26, 2024 |